as on January 8, 2026 at 2:29 am IST
Day's Low
Day's High
6.49%
Downside
0.88%
Upside
52 Week's Low
52 Week's High
8.26%
Downside
371.98%
Upside
Check Reshape Lifesciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$29.9M
EPS (TTM)
-0.42
Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
0.00%
Compare market cap, revenue, PE, and other key metrics of Reshape Lifesciences Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $29.9M | NA | NA | 0.00% | |
| BUY | $37.5B | 423.34% | -16.34 | -264.83% | |
| BUY | $53.7B | 188.08% | 1451.43 | 1.36% | |
| BUY | $120.1B | 104.28% | 33.01 | 31.35% | |
| BUY | $82.3B | 62.87% | 18.62 | 32.13% |
Search interest for Reshape Lifesciences Inc Stock has decreased by -34% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 167.8% return, outperforming this stock by 264.9%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 851.4% return, outperforming this stock by 951.4%
Profit Down
![]()
Netprofit is down for the last 3 quarters, 1.47M → -8.59M (in $), with an average decrease of 252.6% per quarter
Price Dip
![]()
In the last 1 month, HIND stock has moved down by -40.5%
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 1.24M → 34.62K (in $), with an average decrease of 97.2% per quarter
| Organisation | Reshape Lifesciences Inc |
| Headquarters | Harvard Square, Cambridge, MA, United States, 02138 |
| CEO | Mr. Venkateswarlu Nelabhotla M.B.A. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Shiladitya Sengupta M.Sc., Ph.D. | Co-Founder, Director and Member of Scientific & Clinical Advisory Board |
Mr. Robert Dickey IV | Chief Financial Officer |
Dr. Richard Fahrner Ph.D. | Chief Technology Officer |
Dr. Charles G. Chavdarian Ph.D. | Senior Vice President of Product Development & Regulatory CMC |
Dr. Tamara Agajanov M.D. | Senior Vice President of Clinical Development |
Mr. Venkateswarlu Nelabhotla M.B.A. | Co-Founder, CEO, President & Director |
Reshape Lifesciences Inc share price today is $3.39 as on at the close of the market. Reshape Lifesciences Inc share today touched a day high of $3.42 and a low of $3.17.
Reshape Lifesciences Inc share touched a 52 week high of $16 on and a 52 week low of $3.11 on . Reshape Lifesciences Inc stock price today i.e. is closed at $3.39,which is 78.81% down from its 52 week high and 9.00% up from its 52 week low.
Reshape Lifesciences Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Reshape Lifesciences Inc (HIND) shares with as little as ₹89.918 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹899.18 in Reshape Lifesciences Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Reshape Lifesciences Inc share’s latest price of $3.39 as on January 8, 2026 at 2:29 am IST, you will get 2.9499 shares of Reshape Lifesciences Inc. Learn more about
fractional shares .